KRAS and familial pancreatic carcinoma: This notion is supported by a study that examined the dependency on KRAS signaling in pancreatic cancer cell lines that harbor activating mutations in KRAS. Two classes of pancreatic cancer cell lines could be identified, based on their requirement for KRAS signaling to maintain viability.